GANAB as a Novel Biomarker in Multiple Sclerosis: Correlation with Neuroinflammation and IFI35

Multiple sclerosis (MS) still lacks reliable biomarkers of neuroinflammation predictive for disease activity and treatment response. Thus, in a prospective study we assessed 55 MS patients (28 interferon (IFN)-treated, 10 treated with no-IFN therapies, 17 untreated) and 20 matched healthy controls (...

Descripción completa

Detalles Bibliográficos
Autores principales: De Masi, Roberto, Orlando, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625565/
https://www.ncbi.nlm.nih.gov/pubmed/34832977
http://dx.doi.org/10.3390/ph14111195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625565/
https://www.ncbi.nlm.nih.gov/pubmed/34832977
http://dx.doi.org/10.3390/ph14111195

Ejemplares similares